I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 27% ± 9% | |
| microglial cell | 6 studies | 22% ± 6% | |
| oligodendrocyte | 6 studies | 25% ± 7% | |
| regulatory T cell | 5 studies | 18% ± 2% | |
| epithelial cell | 5 studies | 25% ± 8% | |
| oligodendrocyte precursor cell | 5 studies | 30% ± 10% | |
| naive B cell | 4 studies | 22% ± 4% | |
| natural killer cell | 4 studies | 19% ± 4% | |
| GABAergic neuron | 4 studies | 37% ± 13% | |
| astrocyte | 4 studies | 33% ± 8% | |
| glutamatergic neuron | 4 studies | 47% ± 13% | |
| gamma-delta T cell | 4 studies | 19% ± 4% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 21% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 21% ± 4% | |
| mucosal invariant T cell | 3 studies | 19% ± 3% | |
| ciliated cell | 3 studies | 22% ± 7% | |
| goblet cell | 3 studies | 19% ± 2% | |
| pericyte | 3 studies | 16% ± 0% | |
| interneuron | 3 studies | 44% ± 17% |
